T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
McKesson
MCK
|
$1.1B |
| 2 |
Advanced Micro Devices
AMD
|
$673M |
| 3 |
Service Corp International
SCI
|
$664M |
| 4 |
NVIDIA
NVDA
|
$638M |
| 5 |
NXP Semiconductors
NXPI
|
$601M |
Top Sells
| 1 |
Waste Connections
WCN
|
$1.12B |
| 2 |
Exelon
EXC
|
$862M |
| 3 |
Veralto
VLTO
|
$772M |
| 4 |
Intercontinental Exchange
ICE
|
$730M |
| 5 |
Intuit
INTU
|
$708M |
Sector Composition
| 1 | Technology | 25.1% |
| 2 | Healthcare | 21.6% |
| 3 | Consumer Discretionary | 12.25% |
| 4 | Industrials | 10.78% |
| 5 | Financials | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Five Star Bancorp
FSBC
$702M
| $60.2M | 0.04% |
2,026,039
+141,691
| +8% | +$4.21M |
|
377
Xenon Pharmaceuticals
XENE
$3.02B
| $59.2M | 0.04% |
1,503,808
+63,905
| +4% | +$2.52M |
|
378
Celldex Therapeutics
CLDX
$1.52B
| $59M | 0.04% |
+1,734,522
| New | +$59M |
|
379
PRA Group
PRAA
$671M
| $58.9M | 0.04% |
2,631,921
-25,273
| -1% | -$565K |
|
380
Packaging Corp of America
PKG
$19.8B
| $57.9M | 0.03% |
268,965
+47,814
| +22% | +$10.3M |
|
381
International Paper
IP
$25.7B
| $57.8M | 0.03% |
1,183,706
+92,160
| +8% | +$4.5M |
|
382
Progyny
PGNY
$1.94B
| $57.5M | 0.03% |
3,430,045
+1,956,000
| +133% | +$32.8M |
|
383
Nurix Therapeutics
NRIX
$758M
| $57.3M | 0.03% |
2,548,091
+358,899
| +16% | +$8.06M |
|
384
Carpenter Technology
CRS
$12.3B
| $57.2M | 0.03% |
358,587
-207,843
| -37% | -$33.2M |
|
385
Peloton Interactive
PTON
$3.27B
| $57M | 0.03% |
12,184,589
+3,881,420
| +47% | +$18.2M |
|
|
BFS
386
Saul Centers
BFS
$812M
| $56.9M | 0.03% |
1,356,292
-116,084
| -8% | -$4.87M |
|
387
Avanos Medical
AVNS
$590M
| $56.9M | 0.03% |
2,367,045
+149,252
| +7% | +$3.59M |
|
|
CNTA
388
Centessa Pharmaceuticals
CNTA
$2.11B
| $56.9M | 0.03% |
3,556,023
+2,722,030
| +326% | +$43.5M |
|
389
Marriott Vacations Worldwide
VAC
$2.73B
| $56.7M | 0.03% |
771,638
+22,383
| +3% | +$1.64M |
|
390
Orion
OEC
$596M
| $56.7M | 0.03% |
3,181,205
-529,434
| -14% | -$9.43M |
|
391
Equity Bancshares
EQBK
$811M
| $56.2M | 0.03% |
1,374,617
+583
| +0% | +$23.8K |
|
392
Caesars Entertainment
CZR
$5.48B
| $56.2M | 0.03% |
1,345,761
-6,895,406
| -84% | -$288M |
|
393
Iovance Biotherapeutics
IOVA
$901M
| $55M | 0.03% |
5,861,279
+3,810,779
| +186% | +$35.8M |
|
394
Crinetics Pharmaceuticals
CRNX
$3.35B
| $54.6M | 0.03% |
1,068,532
-278,678
| -21% | -$14.2M |
|
395
Pool Corp
POOL
$12.4B
| $54.2M | 0.03% |
143,937
+8,668
| +6% | +$3.27M |
|
396
Cathay General Bancorp
CATY
$3.43B
| $54.2M | 0.03% |
1,261,949
-28,955
| -2% | -$1.24M |
|
397
Advantage Solutions
ADV
$567M
| $53.8M | 0.03% |
15,688,557
+2,403,128
| +18% | +$8.24M |
|
398
Floor & Decor
FND
$9.42B
| $52.9M | 0.03% |
426,009
-100,316
| -19% | -$12.5M |
|
399
Vimeo
VMEO
$734M
| $52.5M | 0.03% |
10,385,947
+16,243
| +0.2% | +$82K |
|
400
Boot Barn
BOOT
$5.58B
| $51.9M | 0.03% |
310,336
-31,117
| -9% | -$5.21M |
|